A Preliminary Gene Expression Profile of Acute Graft-Versus-Host Disease
Allogeneic hematopoietic stem cell transplantation (HSCT) is the treatment of choice for high-risk hematological malignancies, yet a major complication associated with this therapy is acute graft-versus-host disease (GVHD). Despite a well-defined pathophysiological mechanism, there are no definitive...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2008-05-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.3727/096368908785096042 |